Dr. Michael J. Drinnan, MD

Dr. Drinnan practices at Mills-Peninsula Medical Center in Burlingame, California, part of Sutter Health.

Dr. Drinnan's NPI, 1609883024, was assigned on August 1, 2006. Dr. Drinnan graduated from McGill University Faculty of Medicine in 1982. Dr. Drinnan holds California license G50381.

Dr. Drinnan's primary practice is Mills-Peninsula Medical Center, at 1501 Trousdale Drive, Burlingame, CA 94010 in San Mateo County. The practice phone is (650) 696-5400. Dr. Drinnan also practices at Mills Peninsula Medical Center, 100 S San Mateo Dr, San Mateo, CA 94401.

Dr. Drinnan's primary practice is Mills-Peninsula Medical Center in Burlingame, California, part of Sutter Health. The medical group on file is County of Santa Clara Behavioral Health Services, Las Plumas Behavioral Health Clinic. Dmand AI also links Dr. Drinnan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Drinnan practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Drinnan's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Drinnan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Drinnan's licenses on file in 3 states: California, New York and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Drinnan treats.

CMS data shows 1,107 Medicare services from Dr. Drinnan across 13 procedure codes in 2024, for 411 Medicare patients. Medicare paid $131,339 for them.

CMS counts 411 Medicare patients who saw Dr. Drinnan in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Drinnan's median patient age at 78, with 57% women.

In 2024, Dr. Drinnan wrote 291 Medicare Part D claims for 86 patients. 42% of them were for generic drugs. CMS names the drug for 246 of them, across 5 drugs with 11 or more claims each, at $5,561 in total drug cost. In 2023, CMS named 251 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Drinnan for performance year 2024, reported as part of a group. Dr. Drinnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 144 procedures of cataract surgery by Dr. Drinnan, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 54 papers to Dr. Drinnan, published from 2005 to 2015. 2006 was the busiest year, with 2. The most frequent topics are Urodynamics, Deglutition Disorders and Deglutition. Dr. Drinnan has published most often in J Urol. Dr. Drinnan's most frequent co-authors are David J. Howard, MD, PhD and Michael F. Marmor, MD.

CMS Open Payments shows 21 general payments to Dr. Drinnan from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. RxSight Inc paid the most, $461.

Dmand AI lists 3 awards for Dr. Drinnan, most recently Regional Top Doctor in 2014.

Dr. Drinnan graduated from McGill University Faculty of Medicine in 1982. Dr. Drinnan is a member of AAO.

Dr. Drinnan is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.